EUVIMEDEUVIMED entdecken
Crossref

Experience with pre‐diluted plasma exchange therapy for hyperviscosity syndrome

Shigeyuki Igarashi, Yasutaka Kamikawa, Syuji Ono, Gakuya Maekawa, Hiroyuki Kishigami, Kazuki Kawamura, Takumi Oonogi, Toshihiko Nagano

Therapeutic Apheresis and Dialysis · 2023

DOI: 10.1111/1744-9987.14053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2023. Verfasst von Shigeyuki Igarashi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Engineering, Fukui-ken Saiseikai Hospital, Fukui, Japan. Hauptthemen laut MEDLINE: Waldenstrom Macroglobulinemia, Multiple Myeloma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Plasma exchange therapy (PE) is useful for patients with primary macroglobulinemia and multiple myeloma who present with hyperviscosity syndrome. However, hyperviscous blood may coagulate in the circuit during treatment, and in that case necessitate discontinuation of the treatment. This time, we report that we were able to prevent coagulation in the circuit by adding some ideas during the membrane separation method.

Methods

Physiological saline is injected in front of the plasma separation membrane to pre‐dilute the blood, followed by filtration through the plasma separation membrane.

Results

As a result of pre‐diluting with physiological saline to reduce the viscosity entering the separation membrane, it was possible to process the planned target amount.

Conclusion

In patients with hyperviscosity syndrome who showed intracircuit coagulation during plasma exchange therapy, devising a predilution method should be considered as one of the ways to continue treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Waldenstrom MacroglobulinemiaMultiple MyelomaHumansPlasma ExchangeBlood ViscosityPlasmapheresisSyndrome

Stichwörter der Autor:innen

hyperviscosity syndromeintracircuit coagulationplasma exchangepre-dilution

Autor:innen und Institutionen

  • Department of Clinical Engineering, Fukui-ken Saiseikai Hospital, Fukui, Japan.
  • Department of Internal Medicine, Fukui-ken Saiseikai Hospital, Fukui, Japan.

Zitieren

APA

Igarashi, S., Kamikawa, Y., Ono, S., Maekawa, G., Kishigami, H., Kawamura, K., Oonogi, T., & Nagano, T. (2023). Experience with pre‐diluted plasma exchange therapy for hyperviscosity syndrome. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14053

Vancouver

Igarashi S, Kamikawa Y, Ono S, Maekawa G, Kishigami H, Kawamura K, et al. Experience with pre‐diluted plasma exchange therapy for hyperviscosity syndrome. Therapeutic Apheresis and Dialysis. 2023. doi:10.1111/1744-9987.14053

BibTeX
@article{Igarashi2023,
  author = {Igarashi, Shigeyuki and Kamikawa, Yasutaka and Ono, Syuji and Maekawa, Gakuya and Kishigami, Hiroyuki and Kawamura, Kazuki and Oonogi, Takumi and Nagano, Toshihiko},
  title = {Experience with pre‐diluted plasma exchange therapy for hyperviscosity syndrome},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2023},
  doi = {10.1111/1744-9987.14053}
}
Kostenlos starten →